Breast cancer is the most common type of cancer in women, and one of the main causes of death in women. According to the American Society of Clinical Oncology (ASCO) only in the US, 266,600 women will be diagnosticated with this disease and 6% of these women will be in the metastatic stage. The 5-year survival rate is only about 27%, that’s why diagnosis in early stages is still the best way to increase the chances of survival due to the lack of treatments for advanced and metastatic breast cancer.
The most common type of cancer is Adenocarcinoma, which is generated from epithelial cells, and can be found in an invasive form (infiltrating ductal carcinoma or infiltrating lobular carcinoma) or in a non-invasive form called “in situ” (Ductal carcinoma in situ or Lobular carcinoma in situ. Another less common cancer types are Sarcomas, Angiosarcoma, Inflammatory breast cancer, Paget’s disease of the breast and, Phyllodes tumors.
Some symptoms that all types share are changes in the size or shape of one or both breast, discharge from either of your nipples, which may be streaked with blood, lumps or swelling in either of your armpits, dimpling or rash on breast skin or nipples, and changes in the appearance of nipples, if any of this symptoms appear is necessary to go to a specialist to discard any malignancy.
Breast self-examination is nowadays the best way of preventing this disease, it is recommended to do this practice once a month, but if you match any risk factor, is it recommended to do it a little more often. Some of the risk factors are to be old, any medical history of any breast condition, radiation exposure, obesity, having the first period at a young age, never have been pregnant, being on hormone therapy.
Up to date, treatments for advanced stages of this disease are still in progress, here in Althian we have many protocols on the run, including for breast cancer, in the search of a new drug that will help in the battle against this cancer. If you have any doubts or interest in this treatment don’t hesitate to contact us.